Albemarle clears key 200-day line, shares trade lower in S&P 500 chemicals peer group
Published on 06/25/2026 at 15:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBy Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 15:49.
Albemarle Corp. (US0126531013) starts Thursday trading on the NYSE with a technical overhang. The lithium producer’s shares recently traded below their 200-day moving average around 147 dollars, according to a Nasdaq technical note.Nasdaq technical commentary on ALB
What recent data show
In the latest full session on 24 June 2026, Albemarle shares closed at 147.67 dollars on the NYSE, with an intraday range between 146.40 and 150.50 dollars, according to MarketBeat.MarketBeat ALB quote and statistics The stock sits well below its recent 50-day range high of about 215.42 dollars, highlighting a marked pullback from earlier in the quarter.
Real-time quote data from Financialdata.net put Albemarle at around 143.12 dollars in early 25 June trading, a decline of roughly 3.2 percent versus the previous close, with the update timestamped shortly after the US market open.Financialdata.net live ALB quote Over the past year the shares have traded between 58.85 and 221 dollars, according to Nasdaq, underlining the volatility investors have faced.Nasdaq technical commentary on ALB
Chart level and volatility focus
Nasdaq highlighted this week that Albemarle shares recently broke below their 200-day moving average near 147 dollars, a level traders often watch as a medium-term trend gauge.Nasdaq technical commentary on ALB Crossing under this line can signal a weaker momentum phase for many quantitative and technical strategies.
On 25 June 2026, Financialdata.net shows Albemarle changing hands around 143 dollars, clearly under that referenced 200-day band, which keeps the technical picture cautious for now.Financialdata.net live ALB quote The company remains part of the S&P 500 and competes with other specialty chemicals names exposed to electric-vehicle and battery materials demand.
Background and price data on Albemarle
All current news, historical prices and key figures for Albemarle shares are bundled on the dedicated topic page and on the company’s own investor-relations site.
How analysts view Albemarle
MarketBeat compiles 20 Wall Street ratings on Albemarle with a current consensus of “Moderate Buy” and an average price target around 214 to 215 dollars per share, clearly above the present trading zone in the mid-140s.MarketBeat ALB consensus and targets Estimates for the next earnings report point to continued profitability, despite cyclical lithium pricing pressure.MarketBeat ALB earnings calendar
The same MarketBeat data show that Albemarle’s next scheduled earnings date is in early August 2026, aligning it with the broader S&P 500 reporting season.MarketBeat ALB earnings calendar For investors tracking both fundamentals and charts, the combination of a below-200-day share price and higher average target may frame upcoming volatility.
The products behind the lithium name
Albemarle generates a large share of its revenue from lithium compounds used in rechargeable batteries, notably lithium hydroxide and lithium carbonate for electric vehicles and stationary energy storage systems.Financialdata company profile for Albemarle The group also supplies bromine-based flame retardants and catalysts for refining and petrochemical applications, giving it exposure beyond the EV cycle.
Where the shares trade today
The Albemarle shares (US0126531013) trade on 2026-06-25, 15:30, on the NYSE at 143.12 dollars based on Financialdata.net, reflecting early-session levels in New York.Financialdata.net live ALB quote
Key data on the Albemarle shares
- Company: Albemarle Corporation
- ISIN: US0126531013
- WKN: 890167
- Ticker: ALB
- Trading venue: NYSE
- Price (as of 2026-06-25, 15:30): 143.12 USD
- Market cap: 16.4 billion USD (as of 2026-06-25)
- Sector / industry: Basic Materials / Specialty Chemicals
- Index membership: S&P 500
- Next earnings date: 2026-08-06
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All data are based on sources believed to be reliable but cannot be guaranteed.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
